Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Yield per half year: -9.11%
Industry: Leveraged Equities

Category	Share, %	Quantity
Healthcare	73.60824	43

Exchange	Share, %	Quantity
NASDAQ	67.44	29
New York Stock Exchange	32.56	14

Share by country

Country	Quantity	Companies
United States	40	Axsome Therapeutics, Inc. (share - 3.34%) Bristol-Myers (share - 3.08%) Corcept Therapeutics Incorporated (share - 3.07%) Intra-Cellular Therapies, Inc. (share - 2.94%) Zoetis (share - 2.9%) Johnson & Johnson (share - 2.89%) Viatris (share - 2.87%) Catalent (share - 2.77%) PFIZER (share - 2.74%) Eli Lilly and Company (share - 2.7%) Royalty Pharma plc (share - 2.62%) Organon & Co. (share - 2.45%) Merck & Co (share - 2.32%) Cassava Sciences, Inc. (share - 2.13%) Arvinas, Inc. (share - 2.13%) Ocular Therapeutix, Inc. (share - 2.04%) Elanco Animal Health (share - 2%) Amphastar Pharmaceuticals, Inc. (share - 1.8%) Prestige Consumer Healthcare Inc. (share - 1.7%) Tarsus Pharmaceuticals, Inc. (share - 1.64%) Edgewise Therapeutics, Inc. (share - 1.6%) Collegium Pharmaceutical, Inc. (share - 1.57%) Supernus Pharmaceuticals, Inc. (share - 1.54%) Ligand Pharmaceuticals Incorporated (share - 1.36%) Harmony Biosciences Holdings, Inc. (share - 1.33%) Longboard Pharmaceuticals, Inc. (share - 1.25%) Harrow Health, Inc. (share - 1.12%) Evolus, Inc. (share - 1.02%) Innoviva, Inc. (share - 0.9555%) Amneal Pharmaceuticals, Inc. (share - 0.9541%) ANI Pharmaceuticals (share - 0.901%) Liquidia Corporation (share - 0.7492%) Pacira BioSciences, Inc. (share - 0.6859%) Mind Medicine (MindMed) Inc. (share - 0.6567%) EyePoint Pharmaceuticals, Inc. (share - 0.5957%) Enliven Therapeutics, Inc. (share - 0.4809%) Pliant Therapeutics, Inc. (share - 0.4518%) Xeris Pharmaceuticals, Inc. (share - 0.364%) Nuvation Bio Inc. (share - 0.2879%) Fulcrum Therapeutics, Inc. (share - 0.1844%)
Ireland	2	Perrigo (share - 2.59%) Jazz Pharmaceuticals plc (share - 2.52%)
Singapore	1	Wave Life Sciences Ltd. (share - 0.2923%)

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe